MentionFox
Home › Stakes › Park Ha Biological Technology Co., Ltd.
5%+ stakes · Schedule 13D and 13G

Park Ha Biological Technology Co., Ltd.: 5%+ holders

Who has reported owning 5% or more of Park Ha Biological Technology Co., Ltd., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more8
Filings8
Latest filing2026-08-13

Park Ha Biological Technology Co., Ltd. has 8 Schedule 13D or 13G filings on record since 2026-08-10. 8 holders' latest filing reports 5% or more of class a ordinary shares, par value $0.008 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Corin Global Partners Holdings Limited9.8%422,500SCHEDULE 13G, 2026-08-102026-08-03
Peverel Summit Holdings Limited9.8%422,500SCHEDULE 13G, 2026-08-102026-08-03
Rove Trading Co., Limited9.8%422,500SCHEDULE 13G, 2026-08-102026-08-03
Velociti Group Limited9.8%422,500SCHEDULE 13G, 2026-08-102026-08-03
Fusen Advertising Design Limited9.8%422,500SCHEDULE 13G, 2026-08-102026-08-03
Motovance Holdings Limited9.7%422,500SCHEDULE 13G, 2026-08-132026-08-03
Nexera Technology Company Limited9.1%390,000SCHEDULE 13G, 2026-08-102026-08-03
Pinnacle International Holding Limited7.6%325,000SCHEDULE 13G, 2026-08-102026-08-03

Timeline

FiledHolderPercentFiling
2026-08-10Corin Global Partners Holdings Limited9.8%SCHEDULE 13G
2026-08-10Peverel Summit Holdings Limited9.8%SCHEDULE 13G
2026-08-10Rove Trading Co., Limited9.8%SCHEDULE 13G
2026-08-10Velociti Group Limited9.8%SCHEDULE 13G
2026-08-10Nexera Technology Company Limited9.1%SCHEDULE 13G
2026-08-10Pinnacle International Holding Limited7.6%SCHEDULE 13G
2026-08-10Fusen Advertising Design Limited9.8%SCHEDULE 13G
2026-08-13Motovance Holdings Limited9.7%SCHEDULE 13G

Tools for this story

Each opens in a new tab, filled in for Park Ha Biological Technology Co., Ltd.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/park-ha-biological-technology-co
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Park Ha Biological Technology Co., Ltd. 5%+ holders: 8 at 5% or more, largest Corin Global Partners Holdings Limited 9.8%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/park-ha-biological-technology-co